WHAT CAN I EXPECT FROM THIS BRAND? DEVELOPMENT AND VALIDATION OF A CONSUMER-BRAND RELATIONSHIP NORMS SCALE

David Bourdin,Katerina Makri,Georgios Halkias 글로벌지식마케팅경영학회 2023 Global Marketing Conference Vol.2023 No.07

Consumers sometimes see brands as relationship partners and expect that they conform to certain expectations, or relational norms. However, there is no valid and universal operationalization of these norms for the specific context of consumer-brand relationships. We address this gap by developing and validating a new scale in four studies.

La France et ses langues régionales

Maryse Bourdin,김희경,박진석,최내경 중앙대학교 외국학연구소 2023 외국학연구 Vol.- No.64

The French language seems so closely associated with France that it has almost become a symbol of the country itself. The Constitution recognizes French as the sole official language of the Republic. Yet until the end of the 19th century French was not the mother tongue of most French people. In fact, many other idioms such as Corsican, Basque or Alsatian are still in use today. But are they ‘real’ languages, dialects, or mere variants of French? This article explains the historical and political reasons why local languages have long been despised and even fought by central power. We show that even after decades of attempts to suppress them, there are still people ready to fight for this aspect of cultural diversity. We look over major studies conducted to identify local languages, from the Revolution until a 1999 survey which concluded that the total number of languages still in use in France today amounts to no less than 75, when taken into account all overseas territories. We show the slow and difficult process to give them some legal recognition. France must act swiftly if it is to have a chance to pass on to future generations this aspect of its lesser known heritage.

THE DIRECT, INDIRECT, AND CONDITIONAL EFFECTS OF A FOREIGN EMPLOYEE’S ACCENT ON CUSTOMER PARTICIPATION IN SERVICES

David Bourdin,Christina Sichtmann 글로벌지식마케팅경영학회 2020 Global Marketing Conference Vol.2020 No.11

급체 후유증

마리즈 부르뎅(Maryse Bourdin) 샘터사 1994 월간 샘터 Vol.25 No.11

프랑스어 의성어의 한국어 번역에 관한 연구: <아스테릭스(Astérix)>의 사례를 중심으로

김희경,박진석,Maryse Catherine Bourdin,최내경 한국프랑스문화학회 2023 프랑스문화연구 Vol.56 No.1

Ce travail consiste à analyser des exemples d’onomatopées tirés de la série de bande dessinée Astérix. Pour nous, les onomatopées sont des signes arbitraires, qui doivent par conséquent être traduits. Le coq ne chante pas de la même manière en français et en coréen, bien qu’on retrouve des traits communs phonologiques entre ces différentes onomatopées, et une certaine conventionalité demeure donc. Ce sont des mots ou des expressions qui restent dans l’ensemble fidèles au système phonologique de la langue où ils se situent. Comparée à la langue française, la langue coréenne comprend de nombreuses onomatopées, des mots qui sont à la fois des onomatopées et des idéophones, et des idéophones. Contrairement aux onomatopées qui miment le son, les idéophones décrivent une sensation, une forme ou un mouvement. Les idéophones sont développés dans la langue coréenne, ce qui permet de rendre la subtilité des nuances. Ce travail se divisera en trois étapes. En premier lieu, nous travaillerons sur l’aspect de la traduction en essayant de comprendre le rôle et les caractéristiques des onomatopées, utilisées dans la bande dessinée. Dans les vignettes, les onomatopées fonctionnent comme une phrase complète, accompagnée de signe d’exclamation sans les bulles et le cartouche. En second lieu, nous comprendrons le fait suivant : le traducteur ne choisit pas la stratégie de la traduction par l’emprunt, mais il traduit les onomatopées du français en coréen en essayant de recourir à l’exemple du type exclamatif + expression idiomatique ou aux onomatopées coréennes du type divers pour la compréhension des lecteurs. En troisième lieu, nous nous concentrons sur les exemples des onomatopées françaises qui se prêtent à la traduction en idéophones coréens. Selon nous, il est important de traduire les exemples des onomatopées utilisées dans la bande dessinée en tenant compte de la condition pragmatique et de la situation contextuelle pour la compréhension des textes par le lecteur. 이 연구의 목적은 만화 <아스테릭스(Astérix)>에 사용된 프랑스어 의성어가 한국어로 번역되는 양상을 살펴보는 것이다. 의성어는 일반어휘와는 구별되는 특성을 가지고 있다. 의성어는 소리를 묘사하는 말로 감각적 표현 가치를 위해 사용되는 어휘 부류에 속한다. 프랑스어 의성어는 문학작품이나 소설보다는 만화에서 많이 볼 수 있다. 그리하여 의성어가 가장 많이 사용되면서도 정제된 예문을 보여줄 분석 자료로서 만화 <아스테릭스(Astérix)>를 선택하였다. 한국어처럼 의성어를 풍부하게 가진 언어도 드물지만, 프랑스어 의성어의 한국어 번역은 번역자에게 쉽지 않은 작업이다. 의성어는 실제로 사전에 등재되지 않았거나 사전에 등재되어 있더라도 사전적 용법과 다른 문맥에서 사용되기도 하고 형태의 변형이 상당히 자유롭게 허용되어서 비규범적 표기가 많이 존재하기 때문이다. 프랑스어 의성어가 한국어로 번역되는 양상을 살펴보기 위해, 우선 의성어가 가진 의미 특성과 감각적 표현력의 가치를 알아보았고, 다음으로 프랑스어 의성어가 한국어로 번역되는 과정에서 한국어 의성어나 의성의태어, 의태어로 번역되는 사례를 차례로 분석하였다. 이 연구는 도착어 독자들의 이해를 위한 의성어의 번역에서 의성어가 가지는 특성과 표현력에 대한 이해와 함께 상황 의미와 맥락 의미를 고려하는 차원이 가장 중요하다는 문제의식을 기반으로 한다.

High Velocity Compaction : Overview of Materials, Applications and Potential

Dore Florence,Lazzarotto Ludovic,Bourdin Stephane 한국분말야금학회 2006 한국분말야금학회 학술대회논문집 Vol.2006 No.1

Through different projects, CETIM and its scientific and industrial partners have evaluated the potential of the High Velocityy Compaction Technology in terms of materials and component shape. Various kinds of powder materials were studied: metals, ceramics and polymers. The HVC process was used with success to manufacture gears, large parts and multilevel components. Due to the high density of HVC parts, the green machining process enables shapes to be produced that would otherwise be impossible to compact and components to be produced with very hard sintered and homogeneous materials.

TITRES, DIALECTE, PONCTUATION, DISCOURS INDIRECT LIBRE, MONOLOGUES... : LES CHOIX DIFFICILES DU TRADUCTEUR

( Kim Kyunghee ),( Maryse Bourdin ) 한국프랑스어문교육학회 2016 한국프랑스어문교육학회 학술대회자료집 Vol.2016 No.10

In vitro and in vivo experimental models for drug screening and development for Chagas disease.

Romanha, Alvaro José,Castro, Solange Lisboa de,Soeiro, Maria de Nazaré,Correia,Lannes-Vieira, Joseli,Ribeiro, Isabela,Talvani, André,Bourdin, Bernadette,Blum, Bethania,Olivieri, Bian O Instituto 2010 Memórias do Instituto Oswaldo Cruz Vol.105 No.2

<P>Chagas disease, a neglected illness, affects nearly 12-14 million people in endemic areas of Latin America. Although the occurrence of acute cases sharply has declined due to Southern Cone Initiative efforts to control vector transmission, there still remain serious challenges, including the maintenance of sustainable public policies for Chagas disease control and the urgent need for better drugs to treat chagasic patients. Since the introduction of benznidazole and nifurtimox approximately 40 years ago, many natural and synthetic compounds have been assayed against Trypanosoma cruzi, yet only a few compounds have advanced to clinical trials. This reflects, at least in part, the lack of consensus regarding appropriate in vitro and in vivo screening protocols as well as the lack of biomarkers for treating parasitaemia. The development of more effective drugs requires (i) the identification and validation of parasite targets, (ii) compounds to be screened against the targets or the whole parasite and (iii) a panel of minimum standardised procedures to advance leading compounds to clinical trials. This third aim was the topic of the workshop entitled Experimental Models in Drug Screening and Development for Chagas Disease, held in Rio de Janeiro, Brazil, on the 25th and 26th of November 2008 by the Fiocruz Program for Research and Technological Development on Chagas Disease and Drugs for Neglected Diseases Initiative. During the meeting, the minimum steps, requirements and decision gates for the determination of the efficacy of novel drugs for T. cruzi control were evaluated by interdisciplinary experts and an in vitro and in vivo flowchart was designed to serve as a general and standardised protocol for screening potential drugs for the treatment of Chagas disease.</P>

Dupilumab Long-term Safety and Efficacy in Patients with Asthma: Liberty Asthma Traverse

( Hae Sim Park ),( Michael E. Wechsler ),( Linda B. Ford ),( Jorge F. Maspero ),( Ian D. Pavord ),( Yuji Tohda ),( David Langton ),( Christian Domingo ),( Alberto Papi ),( Arnaud Bourdin ),( Henrik Wa 대한결핵 및 호흡기학회 2020 대한결핵 및 호흡기학회 추계학술대회 초록집 Vol.128 No.0

Background Dupilumab, a fully human monocolonal antibody, blocks the shared receptor component for interleukin (IL) 4 and IL 13, key and central drivers of type 2 inflammation in multiple diseases. The efficacy and safety of dupilumab in asthma have been demonstrated up to 52 weeks in phase 2 and phase 3 studies. This open-label extension (OLE) study (NCT02134028) assessed long-term safety and efficacy of dupilumab in adult and adolescent patients who had completed a dupilumab asthma study (phase 2b DRI, phase 2 EXPEDITION, phase 3 QUEST, or phase 3 VENTURE). Methods Patients with moderate-to-severe or oral corticosteroid (OCS)-dependent severe asthma received add on subcutaneous dupilumab 300 mg every 2 weeks (q2w) up to 96 weeks. Treatment-emergent adverse events (TEAEs), annualized rate of severe asthma exacerbations (AER) during the treatment period, change from parent study baseline (PSBL) in forced expiratory volume in 1 second (FEV1), and biomarkers up to Week 96 were assessed. Results 2,282 patients were enrolled overall. Patient safety profile was consistent with the parent studies (Table). The low unadjusted AER and improvement in FEV1 observed in the parent studies were sustained during the OLE. Similar efficacy was seen in patients with elevated type 2 biomarkers from DRI/QUEST. By Week 96, blood eosinophils decreased to below-PSBL levels in patients from DRI/QUEST and were near-PSBL levels in patients from VENTURE; total IgE levels decreased by 82% (median percent change from PSBL). Conclusion Long-term use of dupilumab was well tolerated and showed sustained efficacy in asthma patients up to 96 weeks.